Published in Ann Dermatol on February 14, 2013
Psoriasis. N Engl J Med (2009) 8.80
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol (2001) 3.92
Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol (1999) 3.60
Psoriasis--epidemiology and clinical spectrum. Clin Exp Dermatol (2001) 2.56
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med (2003) 2.12
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Current severe psoriasis and the rule of tens. Br J Dermatol (2005) 1.46
Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol (2007) 1.34
Current and future management of psoriasis. Lancet (2007) 1.29
Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol (2008) 1.28
Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol (2002) 1.21
Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol (2002) 1.16
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol (2000) 1.12
Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol (2009) 1.12
Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol (2006) 1.11
The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol (2000) 1.10
The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res (2001) 1.06
Effects of patient satisfaction with care on health-related quality of life: a prospective study. J Eur Acad Dermatol Venereol (2005) 1.06
Psoriasis and its management. BMJ (2006) 1.05
Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial. Br J Dermatol (2007) 1.03
Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol (2001) 1.02
Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group. Br J Dermatol (1999) 0.96
Psoriasis from the patient's point of view. Arch Dermatol (2001) 0.90
Systemic ciclosporin and tacrolimus in dermatology. Dermatol Ther (2007) 0.89
Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study. J Am Acad Dermatol (2001) 0.85
Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Clin Dermatol (2008) 0.84
Socioeconomic disability in psoriasis. Br J Dermatol (2009) 0.83
Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral). Qual Life Res (2004) 0.81
The use of ciclosporin in psoriasis: a clinical review. Br J Dermatol (2004) 0.81
Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis. J Eur Acad Dermatol Venereol (2007) 0.79
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med (2002) 5.50
US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care (2010) 4.65
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood (2009) 3.47
Interventions for preventing falls in acute- and chronic-care hospitals: a systematic review and meta-analysis. J Am Geriatr Soc (2007) 3.14
High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation (2012) 2.94
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol (2007) 2.71
Economic effects of pharmacists on health outcomes in the United States: A systematic review. Am J Health Syst Pharm (2010) 1.58
Characteristics and effectiveness of fall prevention programs in nursing homes: a systematic review and meta-analysis of randomized controlled trials. J Am Geriatr Soc (2015) 1.49
Improving nurse-to-patient staffing ratios as a cost-effective safety intervention. Med Care (2005) 1.49
Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest (2006) 1.39
Fixed drug eruption due to fluconazole: a third case. J Am Acad Dermatol (2002) 1.35
Use of electronic monitoring induces a 40-day intervention effect in HIV patients. J Acquir Immune Defic Syndr (2006) 1.33
The effectiveness of inpatient geriatric evaluation and management units: a systematic review and meta-analysis. J Am Geriatr Soc (2009) 1.22
Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant (2006) 1.17
Comparative cost-efficiency across the European G5 countries of various regimens of filgrastim, biosimilar filgrastim, and pegfilgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia. J Oncol Pharm Pract (2011) 1.13
Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the Integrative Model of Behavioral Prediction: a cross-sectional study. Clin Transplant (2009) 1.12
Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study. Eur J Cancer (2009) 1.08
Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study. Clin Ophthalmol (2013) 1.05
Work environment and workforce problems: a cross-sectional questionnaire survey of hospital nurses in Belgium. Int J Nurs Stud (2006) 1.04
Health and ill health of asylum seekers in Switzerland: an epidemiological study. Eur J Public Health (2009) 0.97
Measuring symptom experience of side-effects of immunosuppressive drugs: the Modified Transplant Symptom Occurrence and Distress Scale. Transpl Int (2008) 0.97
Implementation of discharge management for geriatric patients at risk of readmission or institutionalization. Int J Qual Health Care (2006) 0.95
Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer. Ther Adv Med Oncol (2012) 0.95
Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastim. Crit Rev Oncol Hematol (2010) 0.94
The cost of war and the cost of health care - an epidemiological study of asylum seekers. Swiss Med Wkly (2011) 0.94
Using PDAs for data collection. Appl Nurs Res (2004) 0.94
Detectability and appraisal thresholds of split pulse signals for the MemoPatch™ device, an electronic skin patch intended to deliver tactile medication reminder signals (study TS-104). Conf Proc IEEE Eng Med Biol Soc (2013) 0.89
Nurses Improving Care for Healthsystem Elders (NICHE): using outcomes and benchmarks for evidenced-based practice. Geriatr Nurs (2002) 0.88
Nurses' responses to ethical dilemmas in nursing practice: meta-analysis. J Adv Nurs (2008) 0.87
Description, specifications, and ASIC configurations of MEMOPATCH, a transdermal pulse generator medical device to promote patient compliance with medication regimens. Conf Proc IEEE Eng Med Biol Soc (2007) 0.87
Update on the MONITOR-GCSF study of biosimilar filgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia in cancer patients: Protocol amendments. Crit Rev Oncol Hematol (2011) 0.86
IMPACT--Integrative Medicine PrimAry Care Trial: protocol for a comparative effectiveness study of the clinical and cost outcomes of an integrative primary care clinic model. BMC Complement Altern Med (2014) 0.86
The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines. Support Care Cancer (2007) 0.86
Explorative study on patient's perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis. Clin Transl Allergy (2012) 0.85
Incidence density and relative risk of nosocomial infection in Taiwan's Only Children's Hospital, 1999-2003. Infect Control Hosp Epidemiol (2008) 0.85
What do language barriers cost? An exploratory study among asylum seekers in Switzerland. BMC Health Serv Res (2010) 0.85
Swiss Interdisciplinary Management Programme for Heart Failure (SWIM-HF): a randomised controlled trial study of an outpatient inter-professional management programme for heart failure patients in Switzerland. Swiss Med Wkly (2011) 0.85
Effectiveness of amlodipine-valsartan single-pill combinations: hierarchical modeling of blood pressure and total cardiovascular disease risk outcomes (the EXCELLENT study). Ann Pharmacother (2011) 0.85
A method for calculating adherence to polypharmacy from dispensing data records. Int J Clin Pharm (2013) 0.85
Supporting medication adherence in renal transplantation--the SMART study. Swiss Med Wkly (2007) 0.84
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study. Intern Emerg Med (2011) 0.84
Distress associated with adverse effects of immunosuppressive medication in kidney transplant recipients. Prog Transplant (2010) 0.84
The professional self-image of nurses in Belgian hospitals: a cross-sectional questionnaire survey. Int J Nurs Stud (2005) 0.83
Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program. Vasc Health Risk Manag (2011) 0.83
Nonadherence to imatinib treatment in patients with gastrointestinal stromal tumors: the ADAGIO study. Anticancer Res (2011) 0.83
Analytical methods and issues for symptom cluster research in oncology. Curr Opin Support Palliat Care (2013) 0.83
Prevalence and correlates of selected alternative and complementary medicine in adult renal transplant patients. Clin Transplant (2008) 0.83
Managing cancer-related anaemia in congruence with the EORTC guidelines is an independent predictor of haemoglobin outcome: initial evidence from the RESPOND study. Eur J Cancer (2008) 0.82
The Strain of Care for Delirium Index: a new instrument to assess nurses' strain in caring for patients with delirium. Int J Nurs Stud (2004) 0.82
Prevalence and contributors to fatigue in individuals hospitalized with advanced cancer: a prospective, observational study. Int J Nurs Stud (2012) 0.82
Prevalence of symptoms, with a focus on fatigue, and changes of symptoms over three months in outpatients receiving cancer chemotherapy. Swiss Med Wkly (2011) 0.82
Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study). Ann Pharmacother (2009) 0.82
Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes. Ann Hematol (2011) 0.82
Prevalence and correlates of influenza vaccination among kidney transplant patients. Prog Transplant (2009) 0.82
Comparison of a computer assisted learning program to standard education tools in hospitalized heart failure patients. Eur J Cardiovasc Nurs (2010) 0.81
Validity testing of the Long-Term Medication Behavior Self-Efficacy Scale. J Nurs Meas (2003) 0.81
Safety of erythropoiesis-stimulating agents in patients with end-stage kidney disease: data are safer than extrapolations. Expert Opin Drug Saf (2012) 0.80
Serial changes in high-sensitivity cardiac troponin I in the early diagnosis of acute myocardial infarction. Int J Cardiol (2013) 0.80
Disorders of calcium homeostasis. Best Pract Res Clin Endocrinol Metab (2003) 0.80
Modelling of blood pressure and total cardiovascular risk outcomes after second-line valsartan therapy: the BSCORE study. Arch Cardiovasc Dis (2011) 0.80
Plasminogen activators are involved in the degradation of bone by osteoclasts. Bone (2008) 0.80
Effects of recombinant human type I pancreatic elastase on human atherosclerotic arteries. J Cardiovasc Pharmacol (2014) 0.79
Emergency department visits in the United States for pediatric depression: estimates of charges and hospitalization. Acad Emerg Med (2014) 0.79
Symptom prevalence and changes of symptoms over ten days in hospitalized patients with advanced cancer: a descriptive study. Eur J Oncol Nurs (2010) 0.79
A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecol Oncol (2013) 0.79
Longitudinal observational studies to study the efficacy-effectiveness gap in drug therapy: application to mild and moderate dementia. Nurs Clin North Am (2006) 0.79
Remission over 3 years in patients with Paget disease of bone treated with a single intravenous infusion of 5 mg zoledronic acid. Calcif Tissue Int (2013) 0.79
Academic Service Partnerships: what do we learn from around the globe? A systematic literature review. Nurs Outlook (2013) 0.78
Neglect assessment in urban emergency departments and confirmation by an expert clinical team. J Gerontol A Biol Sci Med Sci (2005) 0.78
Enhancing ED triage to accommodate the special needs of geriatric patients. J Emerg Nurs (2010) 0.78
The evolving professional nursing self-image of students in baccalaureate programs: a cross-sectional survey. Int J Nurs Stud (2009) 0.78
Promoting evidence-based management of anemia in cancer patients: background, development, and scientific validation of RESPOND, a web-based clinical guidance system based on the EORTC guidelines. Crit Rev Oncol Hematol (2007) 0.77
Intraclass correlation metrics for the accuracy of algorithmic definitions in a computerized decision support system for supportive cancer care. Support Care Cancer (2007) 0.77
State-of-the-art biosimilar erythropoietins in the management of renal anemia: lessons learned from Europe and implications for US nephrologists. Int Urol Nephrol (2015) 0.77
Hierarchical linear and logistic modeling of outcomes of antihypertensive treatment in elderly patients: findings from the PREVIEW study. Arch Gerontol Geriatr (2009) 0.77
Nursing staff attitudes of hip protector use in long-term care, and differences in characteristics between adherent and non-adherent residents: a survey and observational study. Int J Nurs Stud (2010) 0.77